Berkeley Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,752
| Closed | -$308K | – | 162 |
|
|
2021
Q4 | $308K | Sell |
2,752
-22
| -0.8% | -$2.46K | 0.13% | 109 |
|
|
2021
Q3 | $349K | Sell |
2,774
-12
| -0.4% | -$1.51K | 0.16% | 91 |
|
|
2021
Q2 | $377K | Sell |
2,786
-77
| -3% | -$10.4K | 0.17% | 86 |
|
|
2021
Q1 | $388K | Buy |
2,863
+13
| +0.5% | +$1.76K | 0.19% | 78 |
|
|
2020
Q4 | $401K | Sell |
2,850
-151
| -5% | -$21.2K | 0.21% | 72 |
|
|
2020
Q3 | $334K | Buy |
3,001
+108
| +4% | +$12K | 0.2% | 70 |
|
|
2020
Q2 | $324K | Buy |
+2,893
| New | +$324K | 0.2% | 78 |
|
|
2020
Q1 | – | Sell |
-2,918
| Closed | -$278K | – | 139 |
|
|
2019
Q4 | $278K | Buy |
+2,918
| New | +$278K | 0.14% | 114 |
|
|
2019
Q3 | – | Sell |
-3,032
| Closed | -$266K | – | 135 |
|
|
2019
Q2 | $266K | Buy |
3,032
+92
| +3% | +$8.07K | 0.12% | 120 |
|
|
2019
Q1 | $266K | Buy |
+2,940
| New | +$266K | 0.13% | 117 |
|
|
2018
Q3 | – | Sell |
-2,678
| Closed | -$254K | – | 123 |
|
|
2018
Q2 | $254K | Buy |
+2,678
| New | +$254K | 0.15% | 108 |
|
|
2016
Q1 | – | Sell |
-4,308
| Closed | -$302K | – | 124 |
|
|
2015
Q4 | $302K | Buy |
+4,308
| New | +$302K | 0.25% | 79 |
|